Essential Partners’s Progyny PGNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.7K Sell
902
-7
-0.8% -$198 0.01% 867
2026
Q2
$26.2K Buy
909
+75
+9% +$1.68K 0.01% 807
2026
Q1
$14.2K Buy
834
+775
+1,314% +$16.6K ﹤0.01% 1072
2025
Q4
$1.51K Sell
59
-89
-60% -$2.05K ﹤0.01% 1894
2025
Q3
$3.19K Sell
148
-284
-66% -$6.46K ﹤0.01% 1611
2025
Q2
$9.5K Buy
+432
New +$9.47K ﹤0.01% 864

Other funds holding PGNY

Essential Partners's PGNY Position: Q3 2026 in Review

Essential Partners reduced its Progyny (PGNY) stake by 0.77% in Q3 2026, selling an estimated $198 and leaving 902 shares worth $22.7K. The position accounts for 0.01% of the portfolio, ranked #867.

Essential Partners first reported a position in PGNY in Q2 2025 and has held it in 6 quarters since. The position peaked at $26.2K in Q2 2026. 21 funds tracked by Wall St. Rank hold PGNY as of Q3 2026.

  • Essential Partners held 902 shares of Progyny worth $22.7K as of Q3 2026.
  • Essential Partners sold 7 Progyny shares in Q3 2026, an estimated $198.
  • Progyny made up 0.01% of Essential Partners's portfolio in Q3 2026, its #867 holding.
  • Essential Partners first reported a position in Progyny in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Progyny position peaked at $26.2K in Q2 2026.
  • 21 funds tracked by Wall St. Rank held Progyny as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.